BNP Paribas Financial Markets’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $56.3M | Buy |
854,374
+274,512
| +47% | +$17.4M | 0.04% | 620 |
|
|
2025
Q4 | $36.8M | Buy |
579,862
+332,397
| +134% | +$20.7M | 0.02% | 844 |
|
|
2025
Q3 | $13.6M | Sell |
247,465
-42,780
| -15% | -$1.76M | 0.01% | 1346 |
|
|
2025
Q2 | $9.59M | Buy |
290,245
+52,647
| +22% | +$1.83M | 0.01% | 1472 |
|
|
2025
Q1 | $9.55M | Buy |
237,598
+212,951
| +864% | +$9.79M | 0.01% | 1428 |
|
|
2024
Q4 | $1.16M | Sell |
24,647
-15,645
| -39% | -$813K | ﹤0.01% | 2725 |
|
|
2024
Q3 | $2.13M | Sell |
40,292
-15,629
| -28% | -$871K | ﹤0.01% | 2007 |
|
|
2024
Q2 | $3.03M | Sell |
55,921
-115,630
| -67% | -$6.98M | ﹤0.01% | 1674 |
|
|
2024
Q1 | $12M | Sell |
171,551
-27,335
| -14% | -$2.11M | 0.01% | 1007 |
|
|
2023
Q4 | $16.6M | Buy |
198,886
+96,081
| +93% | +$3.48M | 0.03% | 782 |
|
|
2023
Q3 | $3.03M | Buy |
102,805
+46,856
| +84% | +$1.56M | 0.01% | 1617 |
|
|
2023
Q2 | $1.83M | Sell |
55,949
-23,779
| -30% | -$880K | ﹤0.01% | 1809 |
|
|
2023
Q1 | $2.81M | Buy |
79,728
+26,058
| +49% | +$1.06M | 0.01% | 1600 |
|
|
2022
Q4 | $2.46M | Sell |
53,670
-50,534
| -48% | -$2.17M | 0.01% | 1654 |
|
|
2022
Q3 | $5.05M | Buy |
104,204
+43,413
| +71% | +$2.09M | 0.01% | 1360 |
|
|
2022
Q2 | $2.39M | Sell |
60,791
-10,294
| -14% | -$414K | 0.01% | 1650 |
|
|
2022
Q1 | $2.62M | Sell |
71,085
-119,655
| -63% | -$4.25M | 0.01% | 1646 |
|
|
2021
Q4 | $8.69M | Buy |
190,740
+103,685
| +119% | +$4M | 0.02% | 1046 |
|
|
2021
Q3 | $3.11M | Buy |
87,055
+53,389
| +159% | +$1.57M | 0.01% | 1601 |
|
|
2021
Q2 | $666K | Buy |
33,666
+13,659
| +68% | +$321K | ﹤0.01% | 2397 |
|
|
2021
Q1 | $465K | Buy |
20,007
+10,488
| +110% | +$224K | ﹤0.01% | 2598 |
|
|
2020
Q4 | $198K | Sell |
9,519
-7,325
| -43% | -$134K | ﹤0.01% | 2886 |
|
|
2020
Q3 | $365K | Buy |
16,844
+10,410
| +162% | +$244K | ﹤0.01% | 2403 |
|
|
2020
Q2 | $152K | Sell |
6,434
-202,252
| -97% | -$3.79M | ﹤0.01% | 2602 |
|
|
2020
Q1 | $2.46M | Buy |
208,686
+195,837
| +1,524% | +$2.5M | 0.01% | 1365 |
|
|
2019
Q4 | $136K | Buy |
12,849
+5,092
| +66% | +$52.3K | ﹤0.01% | 3141 |
|
|
2019
Q3 | $88.3K | Buy |
7,757
+2,650
| +52% | +$33.3K | ﹤0.01% | 3190 |
|
|
2019
Q2 | $57.5K | Sell |
5,107
-4,464
| -47% | -$43K | ﹤0.01% | 3338 |
|
|
2019
Q1 | $77.4K | Buy |
9,571
+9,555
| +59,719% | +$70.2K | ﹤0.01% | 3268 |
|
|
2018
Q4 | $101 | Sell |
16
-1,520
| -99% | -$11.2K | ﹤0.01% | 4180 |
|
|
2018
Q3 | $15.1K | Hold |
1,536
| – | – | ﹤0.01% | 3540 |
|
|
2018
Q2 | $12.7K | Sell |
1,536
-13,050
| -89% | -$109K | ﹤0.01% | 3680 |
|
|
2018
Q1 | $105K | Sell |
14,586
-4,727
| -24% | -$40.5K | ﹤0.01% | 3152 |
|
|
2017
Q4 | $157K | Sell |
19,313
-5,502
| -22% | -$62.5K | ﹤0.01% | 3076 |
|
|
2017
Q3 | $360K | Buy |
24,815
+11,487
| +86% | +$157K | ﹤0.01% | 2148 |
|
|
2017
Q2 | $161K | Buy |
13,328
+13,036
| +4,464% | +$181K | ﹤0.01% | 2572 |
|
|
2017
Q1 | $3.75K | Sell |
292
-1,613
| -85% | -$18.9K | ﹤0.01% | 3370 |
|
|
2016
Q4 | $23.1K | Sell |
1,905
-376
| -16% | -$3.99K | ﹤0.01% | 3121 |
|
|
2016
Q3 | $20.9K | Buy |
2,281
+964
| +73% | +$10.1K | ﹤0.01% | 2867 |
|
|
2016
Q2 | $12.5K | Buy |
+1,317
| New | +$10.8K | ﹤0.01% | 2795 |
|
|
2016
Q1 | – | Sell |
-6,696
| Closed | -$70K | – | 2771 |
|
|
2015
Q4 | $70K | Sell |
6,696
-1,694
| -20% | -$16.6K | ﹤0.01% | 2563 |
|
|
2015
Q3 | $56.1K | Buy |
8,390
+5,504
| +191% | +$37.6K | ﹤0.01% | 2778 |
|
|
2015
Q2 | $19.4K | Buy |
2,886
+2,066
| +252% | +$13.5K | ﹤0.01% | 3069 |
|
|
2015
Q1 | $5.56K | Buy |
+820
| New | +$6.12K | ﹤0.01% | 3088 |
|
|
2014
Q4 | – | Sell |
-2,116
| Closed | -$7.45K | – | 2269 |
|
|
2014
Q3 | $7.45K | Buy |
2,116
+2,045
| +2,880% | +$8.59K | ﹤0.01% | 3721 |
|
|
2014
Q2 | $339 | Buy |
71
+52
| +274% | +$317 | ﹤0.01% | 3649 |
|
|
2014
Q1 | $86 | Sell |
19
-326
| -94% | -$2.95K | ﹤0.01% | 3308 |
|
|
2013
Q4 | $2.24K | Buy |
+345
| New | +$2.27K | ﹤0.01% | 3608 |
|
Other funds holding CYTK
VPM
VCM
ACA
